Gender differences in genetic susceptibility for lung cancer

Area of Science:

• Environmental Health
• Genetics
• Oncology

Background:

• Lung cancer incidence is rising in women, a trend not fully explained by smoking habits.
• Understanding the genetic basis for this disparity is crucial for targeted prevention and treatment.

Purpose of the Study:

• To investigate the role of specific genetic polymorphisms in cytochrome P450 1A1 (CYP1A1) and glutathione S-transferase M1 (GSTM1) in lung cancer risk among women compared to men.
• To explore the interaction between these genetic factors and smoking history in relation to lung cancer development.

Main Methods:

• Case-control study involving lung cancer patients (n=180) and cancer-free controls (n=163).
• DNA analysis to genotype for CYP1A1 (exon 7) and GSTM1 (null) polymorphisms.
• Smoking history assessment using a questionnaire.

Main Results:

• Women smoked fewer cigarettes (pack-years) than men but exhibited a significantly higher lung cancer risk.
• The mutant CYP1A1 genotype was associated with a substantially increased lung cancer risk in women (OR 4.98) compared to men (OR 1.37).
• Combined CYP1A1 and GSTM1 null genotypes conferred a higher odds ratio for lung cancer in women (OR 6.54) than in men (OR 2.36), independent of smoking history.

Conclusions:

• Genetic polymorphisms in CYP1A1 and GSTM1 appear to contribute significantly to the elevated lung cancer risk observed in women.
• These genetic factors may explain the increasing lung cancer incidence among female smokers, even with lower smoking intensity.